The Antimicrobial Nano-coatings Market in China Anticipated Growth and Key Industry Insights The Antimicrobial Nano-coatings Market in China is estimated to witness a 22.9% growth rate over the coming assessment period of 2022 and 2032. Medical & healthcare is estimated to be a key end-use industry, and the segment is set to account for about…

Immediate Cash Flow Available Through Fast, Flexible and Equitable Bridge Loans Omega Accounting Solutions Launches Omega Funding Solutions: New Third-Party Lender Offering Advances on ERC IRVINE, Calif., Nov. 01, 2022 (GLOBE NEWSWIRE) – According to August reporting—and corroborated by taxpayers reporting 10–12-month delays for receiving their money—the IRS currently has a backlog of more than…

Absa Bank Limited Selects nCino to Optimize its Relationship Banking Debt Management Business JOHANNESBURG, South Africa, Nov. 01, 2022 (GLOBE NEWSWIRE) nCino, Inc. (NASDAQ: NCNO), a pioneer in cloud banking and digital transformation solutions for the global financial services industry, today announced that Absa Bank Limited (Absa), a leading African bank, has selected the nCino…

Rising Prevalence of Thoracic Disorders Generating Growth Opportunities for Thoracic Drainage Device Manufacturers: Fact.MR Analysis Introduction Thoracic disorders, such as pleural effusions and traumatic pneumothorax, are increasingly common in today’s world. As a result, the demand for thoracic drainage devices is on the rise. According to a recent analysis by Fact.MR, global sales of thoracic…

Company Invites all NCLH Shareholders to Submit Questions for Management Ahead of Earnings Call MIAMI, Oct. 31, 2022 (GLOBE NEWSWIRE) — Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (together with NCL Corporation Ltd., “Norwegian Cruise Line Holdings” or the “Company”) announced today it will report third quarter 2022 financial results on Tuesday, November 8, 2022…

Reviva Pharmaceuticals Announces Global Enrollment Update for Pivotal Phase 3 RECOVER Study Evaluating Brilaroxazine for Schizophrenia Enrollment ongoing at multiple sites in the US and Europe; site initiation in Asia expected in November 2022 Enrollment on pace, with over 30% enrolled in the United States Topline data for RECOVER evaluating brilaroxazine for schizophrenia expected in…

Welcome to the Quirky Finance Blog! Bay Community Bancorp: Making Waves in the Financial World Hey there, money-savvy readers! Have you heard the latest buzz in the financial sphere? Well, let me fill you in on the scoop. Bay Community Bancorp, the parent company of Community Bank of the Bay, has been making some serious…

Vyant Bio’s Human First Drug Discovery Platform Platform and Poster Presentations Progress on CDKL5 Deficiency Disorder (CDD) Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders. The Company’s proprietary central nervous system (CNS) platform integrates machine learning and biology to accelerate…